Showing 1 - 20 results of 41,207 for search '(( 50 ((mean decrease) OR (_ decrease)) ) OR ((( 1 linear decrease ) OR ( _ ann decrease ))))*', query time: 0.84s Refine Results
  1. 1
  2. 2

    Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

    Published 2014
    “…At very long prices, as the price is increased further (eg. from 30 s to 50 s), the mode of the leisure duration distribution does not change by much although the mean does. …”
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Decreased oxidative phosphorylation in SDH and VHL-related PH/PGL. by Judith Favier (78711)

    Published 2013
    “…(D–F) Mean values for mitochondrial complexes II+III, III and IV reveal a generalized decrease in respiration in SDH and VHL PH/PGL. …”
  8. 8
  9. 9

    Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

    Published 2016
    “…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”
  10. 10

    Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

    Published 2013
    “…<p>Change in incidence (A) and diagnoses (B) if testing rates decrease by 30% and 50% relative to the current testing rate.…”
  11. 11
  12. 12
  13. 13
  14. 14

    WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

    Published 2013
    “…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [<sup>3</sup>H]-Thymidine incorporation assay. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Image_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.tif by Zijing Ran (11429935)

    Published 2021
    “…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
  20. 20